Ximing Labs Private Limited

Ximing Labs Private Limited

Manufactures pharmaceuticals, chemicals, and botanical products for medical use.
2014 | Banaskantha, Gujarat (India) | Active

Last Updated:

December 30, 2024
HomeCompanyXiming Labs Private Limited

Who are the key members and board of directors at Ximing Labs?

Board Members(4)

NameDesignationAppointment DateStatus
Bhupendra Agraval In Director 11-Dec-2014Current
Jagdishkumar Kugashiya In Director 18-Feb-2016Current
Rishabh Agarwal In Director 30-Sep-2023Current
Rakeshkumar Patel In Director 16-Jan-2018Current

Financial Performance of Ximing Labs.

Ximing Labs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 93.96% increase. The company also saw a substantial improvement in profitability, with a 83.52% increase in profit. The company's net worth moved up by a moderate rise of 1.27%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
93.96%
Revenue from Operations
93.96%
Total Assets
40.22%
Profit or Loss
83.52%
Net Worth
1.27%
EBITDA
-283.04%

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Ximing Labs?

Unlock and access historical data on people associated with Ximing Labs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Ximing Labs

Recent activity within the organization

  • Annual General Meeting

    Ximing Labs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Ximing Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

    31 Mar 2024

  • Director Appointment

    Rishabh Subhashchandra Agarwal was appointed as a Director was appointed as a Director on 30 Sep 2023 & has been associated with this company since 1 year 3 months .

    30 Sep 2023

  • Director Appointment

    Rakeshkumar Kantilal Patel was appointed as a Director was appointed as a Director on 16 Jan 2018 & has been associated with this company since 7 years .

    16 Jan 2018

  • Director Appointment

    Jagdishkumar Nagarbhai Kugashiya was appointed as a Director was appointed as a Director on 18 Feb 2016 & has been associated with this company since 8 years 10 months .

    18 Feb 2016

  • Director Appointment

    Bhupendra Rajendraprasad Agraval was appointed as a Director was appointed as a Director on 11 Dec 2014 & has been associated with this company since 10 years 1 month .

    11 Dec 2014

Frequently asked questions

  • Ximing Labs Private Limited was incorporated on 11 Dec 2014.

  • The authorized share capital of Ximing Labs Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.

  • Currently 4 directors are associated with Ximing Labs Private Limited.

    • Bhupendra Rajendraprasad Agraval
    • Jagdishkumar Nagarbhai Kugashiya
    • Rishabh Subhashchandra Agarwal
    • Rakeshkumar Kantilal Patel
  • As per Ministry of Corporate Affairs (Mca), the registered address of Ximing Labs Private Limited is To- Rampura Po- Sadarpur, Village Taluka: India, Palanpur, Gujarat, 385001.

  • The corporate identification number (CIN) of Ximing Labs Private Limited is U33111GJ2014PTC081498 and the company number is 081498 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2022, the revenue trend for Ximing Labs Private Limited has risen by 93.96%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Ximing Labs Private Limited has experienced an upsurge of 1.27%.

  • The most recent Balance Sheet for Ximing Labs Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development